AOD-9604 is the more-studied stabilized version Compound Human Growth Hormone (somatropin) Class Full-length recombinant hGH FDA Status FDA-approved for specific indications (GH deficiency, certain growth disorders, AIDS wasting) Evidence Strength Strong human evidence for approved indications
Community-reported data The information below reflects self-reported experiences from PeptIQ app users
The items in your order maybe shipped from any of the above jurisdictions
Expectations and timeline Users typically report initial effects within the first two weeks of use
Individuals with malabsorption conditions, severe deficiency, or those who havent responded to oral supplements typically benefit most from injections
The 0.3 mL, 0.5 mL, and 1.0 mL options change capacity, not the unit-to-mL relationship